171 related articles for article (PubMed ID: 36512190)
1. Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study.
Wu B; Li J; Tao X; Wang J; Zhu G; Lu X; Chen R
Reprod Sci; 2023 Jun; 30(6):1927-1937. PubMed ID: 36512190
[TBL] [Abstract][Full Text] [Related]
2. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
[TBL] [Abstract][Full Text] [Related]
3. Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian Tumors.
Dewilde K; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Gynecol Obstet Invest; 2018; 83(1):65-69. PubMed ID: 28689208
[TBL] [Abstract][Full Text] [Related]
4. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
5. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study.
Wang D; Jia S; Jia C; Cao D; Yang J; Yang J; Xiang Y
Gynecol Oncol; 2022 Jun; 165(3):446-452. PubMed ID: 35469684
[TBL] [Abstract][Full Text] [Related]
6. Progression of Cystadenoma to Mucinous Borderline Ovarian Tumor in Young Females: Case Series and Literature Review.
Beroukhim G; Ozgediz D; Cohen PJ; Hui P; Morotti R; Schwartz PE; Yang-Hartwich ; Vash-Margita A
J Pediatr Adolesc Gynecol; 2022 Jun; 35(3):359-367. PubMed ID: 34843973
[TBL] [Abstract][Full Text] [Related]
7. Seromucinous and Mucinous Borderline Ovarian Tumors: We Need to Know More.
Laban M; Chen X; Guo B
Reprod Sci; 2023 May; 30(5):1684-1685. PubMed ID: 36474132
[TBL] [Abstract][Full Text] [Related]
8. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
9. The role of appendectomy in patients with mucinous borderline ovarian tumors.
Song T; Kim MK; Jung YW; Yun BS; Seong SJ; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():112-116. PubMed ID: 30145525
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline Ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
[TBL] [Abstract][Full Text] [Related]
11. Mucinous borderline ovarian tumors with and without Intraepithelial Carcinoma: Differences in clinicopathologic features and fertility results.
Chen RF; Tao X; Wu BB; Li J; Wang JY; Gu WY; Lu X
J Obstet Gynaecol Res; 2020 Apr; 46(4):646-653. PubMed ID: 32045956
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with misdiagnosis of frozen section of mucinous borderline ovarian tumor.
Zhang W; Jia S; Xiang Y; Yang J; Jia C; Leng J
J Int Med Res; 2019 Jan; 47(1):96-104. PubMed ID: 30198356
[TBL] [Abstract][Full Text] [Related]
14. Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center.
Cömert DK; Üreyen I; Karalok A; Taşçı T; Türkmen O; Öcalan R; Turan T; Tulunay G
J Turk Ger Gynecol Assoc; 2016; 17(2):96-100. PubMed ID: 27403076
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.
Hada T; Miyamoto M; Ishibashi H; Kawauchi H; Soyama H; Matsuura H; Sakamoto T; Kakimoto S; Aoyama T; Iwahashi H; Suzuki R; Tsuda H; Takano M
In Vivo; 2020; 34(3):1341-1346. PubMed ID: 32354928
[TBL] [Abstract][Full Text] [Related]
16. [The clinicopathological features and risk factors of recurrence in patients with mucinous borderline ovarian tumors].
Sun L; Song Y; Li N; Yuan GW; Sun YC; Li N; Ma SK; Zhang X; Wu LY
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):589-594. PubMed ID: 28835081
[No Abstract] [Full Text] [Related]
17. Retrospective study of characteristics and hyperthermia intraperitoneal perfusion in mucinous borderline ovarian tumor and mucinous ovarian carcinoma.
He X; Ying R; Jia L; Li Y; Li R
Gland Surg; 2023 Apr; 12(4):453-464. PubMed ID: 37200926
[TBL] [Abstract][Full Text] [Related]
18. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
Okumura T; Muronosono E; Tsubuku M; Terao Y; Takeda S; Maruyama M
J Ovarian Res; 2018 Sep; 11(1):77. PubMed ID: 30176911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]